Anzeige
Mehr »
Freitag, 26.06.2026 - Börsentäglich über 12.000 News
Tagebau oder Tiefsee-Bergbau: Für welchen Fußabdruck entscheidet sich die Welt?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J68D | ISIN: CNE100001M79 | Ticker-Symbol: 08HH
Tradegate
26.06.26 | 14:59
1,661 Euro
-4,07 % -0,071
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD Chart 1 Jahr
5-Tage-Chart
SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,6611,71119:38
1,6611,71119:39

Aktuelle News zur SHANGHAI FOSUN PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
Zeit Aktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12:41FOSUN PHARMA (02196): PROPOSED SPIN-OFF AND SEPARATE LISTING OF FOSUN ADGENVAX ON THE MAIN BOARD OF THE HONG KONG STOCK EXCHANGE3
16.06.FOSUN PHARMA (02196): FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 202511
16.06.FOSUN PHARMA (02196): POLL RESULTS OF THE RESOLUTIONS PROPOSED AT THE AGM THE 2026 SECOND A SHAREHOLDERS' CLASS MEETING AND THE 2026 SECOND H SHAREHOLDERS' ...2
16.06.FOSUN PHARMA Unit Fosun Antengene Raises Nearly RMB1B in Capital Increase, Prepares for Main Board Listing4
16.06.FOSUN PHARMA Luvometinib Tablets Granted Approval for New Indication6
15.06.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL FOR REGISTRATION OF AN ADDITIONAL INDICATION FOR DRUG ...3
SHANGHAI FOSUN PHARMACEUTICAL Aktie jetzt für 0€ handeln
29.05.FOSUN PHARMA Innovative Oncology Immunotherapy FXB0871 Completes First Participant Dosing in China Phase I Trial8
29.05.FOSUN PHARMA, GENRIX Sign Strategic Cooperation Framework Agreement9
21.05.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL FOR DRUG REGISTRATION OF A SUBSIDIARY31
14.05.Fosun Pharma, AriBio Sign Exclusive Global Option Agreement18
14.05.Fosun Pharma to Pay Up to USD240 Million More for Global Rights to AriBio's Early Alzheimer's Drug3
13.05.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE ACCEPTANCE OF A SUBSIDIARY'S DRUG REGISTRATION APPLICATION3
11.05.FOSUN PHARMA (02196): NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED SHAREHOLDERS2
11.05.FOSUN PHARMA (02196): NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS10
11.05.FOSUN PHARMA (02196): FORM OF PROXY FOR HOLDERS OF H SHARES FOR THE 2026 SECOND CLASS MEETING OF HOLDERS OF H SHARES TO BE HELD ON TUESDAY, 16 JUNE 20261
11.05.FOSUN PHARMA (02196): FORM OF PROXY FOR HOLDERS OF H SHARES FOR THE ANNUAL GENERAL MEETING TO BE HELD ON TUESDAY, 16 JUNE 20261
11.05.FOSUN PHARMA (02196): NOTICE OF 2026 SECOND H SHAREHOLDERS CLASS MEETING2
11.05.FOSUN PHARMA (02196): NOTICE OF ANNUAL GENERAL MEETING2
11.05.FOSUN PHARMA (02196): ANNUAL GENERAL MEETING; REMUNERATION MANAGEMENT SYSTEM FOR DIRECTORS AND SENIOR MANAGEMENT; ENTRUSTED LOANS/BORROWINGS QUOTA; AUTHORISATION ...3
08.05.FOSUN PHARMA (02196): OVERSEAS REGULATORY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO THE APPROVAL FOR DRUG REGISTRATION OF A SUBSIDIARY2
Weiter >>
66 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1